Sumitomo Bakelite Company Limited (TYO:4203)

Market Cap	391.90B
Revenue (ttm)	304.77B
Net Income (ttm)	19.28B
Shares Out	87.64M
EPS (ttm)	208.91
PE Ratio	21.41
Forward PE	15.60
Dividend	105.00 (2.37%)
Ex-Dividend Date	Sep 29, 2025

Volume	276,700
Average Volume	235,335
Open	4,362.00
Previous Close	4,424.00
Day's Range	4,362.00 - 4,484.00
52-Week Range	2,750.00 - 4,492.00
Beta	0.51
RSI	76.58
Earnings Date	Aug 4, 2025

About Verve Therapeutics

Sumitomo Bakelite Company Limited, together with its subsidiaries, engages in the research and development, manufacture and sale of semiconductor materials, plastic products, and life products in Japan and internationally. The company offers epoxy resin molding compounds for encapsulation of semiconductor devices, photosensitive coating resins for semiconductor wafers, liquid resins for semiconductor devices, and substrate materials for semiconductor packages. It also provides medical devices and drugs, melamine resin decorative laminates and s...

• Industry: Specialty Chemicals
• Sector: Materials
• Founded: 1932
• Employees: 7,981
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4203

Financial Performance

In 2024, Sumitomo Bakelite Company's revenue was 304.77 billion, an increase of 6.09% compared to the previous year's 287.27 billion. Earnings were 19.28 billion, a decrease of -11.68%.